Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial.
Journal Information
Full Title: Eye Vis (Lond)
Abbreviation: Eye Vis (Lond)
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThis study was approved by the Ethics Committee Review Board of Peking University People’s Hospital (2021PHB405-001). All patients provided written informed consent before surgery. All procedures adhered to the tenets of the Declaration of Helsinki. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
"Funding This study was funded by Capital Clinical Diagnosis and Treatment Technology Research and Demonstration Application Project of China (Grant No. Z191100006619029) and National Key R&D Program of China (Grant No. 2020YFC2008200)."
"Trial registration: Registered at ClinicalTrials.gov ( NCT05414149 )."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025